2012Chinese Journal of Aesthetic MedicineRequires access

The impact of leflunomide on diabetic nephropathy rat NF-κβ, VEGF and TGF-β expression

Zhen Wang

Open publisher page 0 citations

Abstract

Objective To explore the impact of leflunomide on diabetic nephropathy rat NF-κβ,VEGF and TGF-β expression.Methods Through the establishment of a rat model of diabetic nephropathy,studies of leflunomide on NF-κβ,VEGF and TGF-β expression.Results Successfully established a rat model of diabetic nephropathy,studies have shown that leflunomide can down the rats with diabetic nephropathy expression of NF-κβ、VEGF and TGF-β.Conclusion Leflunomide can be an ideal drug for the treatment of diabetic nephropathy,its therapeutic mechanism may be related to lowered NF-κβ,VEGF and TGF-β,specific mechanism needs further study.

About this research paper

What this paper is about

Objective To explore the impact of leflunomide on diabetic nephropathy rat NF-κβ,VEGF and TGF-β expression.Methods Through the establishment of a rat model of diabetic nephropathy,studies of leflunomide on NF-κβ,VEGF and TGF-β expression.Results Successfully established a rat model of diabetic nephropathy,studies have shown that leflunomide can down the rats with diabetic nephropathy expression of NF-κβ、VEGF and TGF-β.Conclusion Leflunomide can be an ideal drug for the treatment of diabetic nephropathy,its therapeutic mechanism may be related to lowered NF-κβ,VEGF and TGF-β,specific mechanism needs further study.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the impact of leflunomide on diabetic nephropathy rat NF-κβ,VEGF and TGF-β expression.Methods Through the establishment of a rat model of diabetic nephropathy,studies of leflunomide on NF-κβ,VEGF and TGF-β expression.Results Successfully established a rat model of diabetic nephropathy,studies have shown that leflunomide can down the rats with diabetic nephropathy expression of NF-κβ、VEGF and TGF-β.Conclusion Leflunomide can be an ideal drug for the treatment of diabetic nephropathy,its therapeutic mechanism may be related to lowered NF-κβ,VEGF and TGF-β,specific mechanism needs further study.

Key concepts: Leflunomide, Diabetic nephropathy, Medicine, VEGF receptors, Transforming growth factor, Nephropathy, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
The impact of leflunomide on diabetic nephropathy rat NF-κβ, VEGF and TGF-β expression — Research Paper | ScholarLens